Bed Bath & Beyond (BBBY) PT Lowered to $15 at Wedbush

Bed Bath & Beyond (BBBY) PT Lowered to $15 at Loop Capital Following 2Q

Loop Capital analyst Anthony Chukumba lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $15.00 (from $18.00) while maintaining a Hold rating following the company's 2Q earnings report. Net sales were roughly flat to F2Q 2017 at $2.9B. Operating margin declined 310 bps YoY to 2.7% and... More

Pre-Open Movers 09/27: (CBMG) (PTGX) (HAIR) Higher; (GERN) (VERU) (BBBY) Lower (more...)

Today's pre-Open Stock Movers

Geron Corporation (Nasdaq: GERN) 70.8% LOWER; announced that Janssen Biotech, Inc. (Janssen) has terminated the 2014 Collaboration and License Agreement (CLA) with the Company. Janssen stated in their press release issued today that they made this decision as the result of a strategic portfolio evaluation and... More

Bed Bath & Beyond (BBBY) PT Lowered to $14 at JPMorgan

JPMorgan analyst Christoper Horvers lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $14.00 (from $16.00) while maintaining an Underweight rating.

The analyst noted gross margin was "much worse than expected, deleveraging ~280 bps to 33.7% (vs. consensus of 35.0%) driven by higher coupons (amount... More

Bed Bath & Beyond (BBBY) PT Lowered to $18 at Credit Suisse

Credit Suisse analyst Seth Sigman lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $18.00 (from $20.00) while maintaining a Neutral rating.

The analyst commented, "BBBY's Q2 was well below expectations and included its weakest GM in years. The -0.6% comps... More

Bed Bath & Beyond (BBBY) PT Lowered to $14 at Deutsche Bank

Deutsche Bank analyst Mike Baker lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $14.00 (from $17.00) while maintaining a Hold rating.

Baker commented, "2Q results missed expectations and showcased profit and margin declines that were not only worse than consensus estimates but are... More

Bed Bath & Beyond (BBBY) PT Lowered to $16 at UBS

UBS analyst Michael Lasser lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $16.00 (from $19.00) while maintaining a Neutral rating.

Options expected to have increasing volume: BBBY GERN

Options expected to have increasing volume: BBBY GERN

After-Hours Stock Movers 09/26: (HAIR) (ALDX) Higher; (VERU) (BBBY) (CMTL) Lower (more...)

Today's After-Hours Stock Movers

Veru Inc. (NASDAQ: VERU) 18.2% LOWER; intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by Veru. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or... More

Bed Bath & Beyond (BBBY) Misses Q2 EPS by 14c

Bed Bath & Beyond (NASDAQ: BBBY) reported Q2 EPS of $0.36, $0.14 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.96 billion.

Comparable Sales Declined Approximately 0.6%

For earnings history and earnings-related data on Bed Bath & Beyond (BBBY) click here.